EU MDR implementation – what is changing for the medical device industry?

AdobeStock_218976146

This article focuses on the impact of the Medical Device Regulation (MDR) transition extension period and provides guidance for medical device manufacturers on the new Regulation (EU) 2023/607. MDR (EU) 2017/745 came into force in May 2017 and became applicable in May 2020. After multiple amendments to the MDR, the date of application (DoA) was extended to 26 May 2021 and transitional provisions set out in the MDR were extended to between 26 May 2026-31 December 2028. The transitional period is extended exclusively for legacy devices that meet the conditions for the application of the new transition period, and the length of the extension depends on the risk class of the specific medical device.

 This is member-only content

To read this article, SIGN IN NOW if you are a TOPRA member.

 

Not a TOPRA member yet? Join our global community.

Five great reasons to become a TOPRA member:

  1. Great savings on our events and training.
  2. Be part of our dynamic international community.
  3. Contribute to the profession.
  4. Grow your skills and knowledge.
  5. Take your career to the next level.

Have you heard what you’re missing? Listen now to the RegRapPod podcast show, for free!